HK1127877A1 - Composition containing peptide as the active ingredient - Google Patents

Composition containing peptide as the active ingredient

Info

Publication number
HK1127877A1
HK1127877A1 HK09107807.9A HK09107807A HK1127877A1 HK 1127877 A1 HK1127877 A1 HK 1127877A1 HK 09107807 A HK09107807 A HK 09107807A HK 1127877 A1 HK1127877 A1 HK 1127877A1
Authority
HK
Hong Kong
Prior art keywords
active ingredient
composition containing
containing peptide
peptide
composition
Prior art date
Application number
HK09107807.9A
Other languages
English (en)
Inventor
Masashi Morifuji
Keiko Kurashige
Chiaki Sanbongi
Original Assignee
Meiji Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Co Ltd filed Critical Meiji Co Ltd
Publication of HK1127877A1 publication Critical patent/HK1127877A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK09107807.9A 2006-04-21 2009-08-25 Composition containing peptide as the active ingredient HK1127877A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006117439 2006-04-21
PCT/JP2007/058620 WO2007123200A1 (fr) 2006-04-21 2007-04-20 Composition contenant un peptide comme principe actif

Publications (1)

Publication Number Publication Date
HK1127877A1 true HK1127877A1 (en) 2009-10-09

Family

ID=38625100

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09107807.9A HK1127877A1 (en) 2006-04-21 2009-08-25 Composition containing peptide as the active ingredient

Country Status (8)

Country Link
US (1) US8343531B2 (fr)
EP (1) EP2039366A4 (fr)
JP (2) JP5645360B2 (fr)
KR (1) KR101652778B1 (fr)
CN (1) CN101426513B (fr)
CA (1) CA2649842C (fr)
HK (1) HK1127877A1 (fr)
WO (1) WO2007123200A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090202704A1 (en) * 2008-02-13 2009-08-13 Kao Corporation Postprandial hyperglycemia-improving agent
DE102008032828A1 (de) * 2008-07-02 2010-01-07 Technische Universität Dresden Tryptophanhaltige Peptide aus alpha-Lactalbumin mit blutdrucksenkender und vasoprotektiver Wirkung für biofunktionelle Lebensmittel
JP5749419B2 (ja) * 2008-12-24 2015-07-15 雪印メグミルク株式会社 筋肉増強剤
US9523109B2 (en) * 2011-06-24 2016-12-20 Calpis Co., Ltd. Method for enzymatically preparing peptides for use in improvement of brain function
JP5877560B2 (ja) * 2012-03-09 2016-03-08 森永乳業株式会社 ジペプチジルペプチダーゼ−ｉｖ阻害剤
WO2014134225A2 (fr) * 2013-02-26 2014-09-04 Pronutria, Inc. Polypeptides nutritifs, formulations et procédés pour traiter des maladies et améliorer la santé et l'entretien musculaire
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
CN103736076B (zh) * 2013-12-30 2015-03-25 浙江省农业科学院 具有降血压和降血脂双功能的二肽dl及其用途
US20170143701A1 (en) * 2014-06-20 2017-05-25 Suntory Holdings Limited Carbohydrate metabolism-ameliorating agent
EP3117831A1 (fr) * 2015-07-16 2017-01-18 Nuritas Limited Peptides destinés à être utilisés pour favoriser le transport du glucose dans le muscle squelettique
EP3118216A1 (fr) 2015-07-16 2017-01-18 Nuritas Limited Peptides favorisant la croissance et la prolifération cellulaire et leurs utilisations
EP3747425A1 (fr) 2015-07-16 2020-12-09 Nuritas Limited Peptides anti-inflammatoirs et leurs utilisations
WO2017026429A1 (fr) * 2015-08-10 2017-02-16 株式会社明治 Agent favorisant la synthèse du muscle
JP2018008916A (ja) * 2016-07-15 2018-01-18 株式会社明治 血中アミノ酸濃度上昇促進剤
JP6826726B2 (ja) * 2017-01-19 2021-02-10 サラヤ株式会社 糖取り込み促進用経口組成物
JP2018123065A (ja) * 2017-01-30 2018-08-09 株式会社明治 インスリン分泌促進用組成物
PL3372671T3 (pl) * 2017-03-09 2022-02-21 Evonik Operations Gmbh Pożywka hodowlana zawierająca oligopeptydy
TWI773739B (zh) * 2017-03-10 2022-08-11 日商明治股份有限公司 用以促進體內ｂｄｎｆ量增加之組成物
WO2019168149A1 (fr) 2018-03-02 2019-09-06 一般財団法人糧食研究会 Peptide pouvant améliorer la fonction cognitive
EP3780973A4 (fr) * 2018-04-18 2022-01-26 Ingenious Ingredients, LP Compositions et procédés d'utilisation correspondants destinés à favoriser la croissance et la fonction musculaires
CN112041328B (zh) * 2018-04-26 2024-06-21 志瑞亚新药工业株式会社 二肽和含有该二肽的药物组合物
JP2020176100A (ja) * 2019-04-22 2020-10-29 株式会社明治 運動誘発性筋損傷を抑制するための組成物
WO2021060927A1 (fr) * 2019-09-25 2021-04-01 매일유업 주식회사 Composition permettant de soulager, de prévenir ou de traiter la sarcopénie, contenant un hydrolysat de protéines de lactosérum en tant que principe actif
JP7475155B2 (ja) * 2020-02-14 2024-04-26 森永乳業株式会社 持久力向上用組成物
CN111855861B (zh) * 2020-07-31 2021-03-19 西湖大学 伴随蛋白/肽在提高蛋白质组实验效率中的应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340592A (en) * 1980-03-14 1982-07-20 Adibi Siamak A Nutrient compositions and method of administering the same
JPS63165833A (ja) * 1986-12-27 1988-07-09 Canon Inc 光学付属品
JPH01228918A (ja) * 1988-03-09 1989-09-12 Nippon Suisan Kaisha Ltd 抗糖尿病剤
DE68905387T2 (de) * 1988-06-22 1993-10-21 Ajinomoto Kk Aminosäure-Nahrungsmittelzusammensetzungen.
JPH03165833A (ja) 1989-02-28 1991-07-17 Isamu Horikoshi 新規懸濁化方法及びこの方法によって得られる組成物
JPH04149139A (ja) 1990-10-12 1992-05-22 Nippon Steel Corp 血糖降下剤
DK0967892T4 (da) * 1996-04-18 2008-01-21 Arla Foods Amba Additiv til brug i et hvilket som helst energisupplement, anvendelse af et proteinhydrolysat til fremstilling af et energisupplement, og et energisupplement indeholdende et sådant additiv
JPH1084911A (ja) * 1996-07-25 1998-04-07 Ota Isan:Kk 血糖上昇抑制用食品素材
DE19823831A1 (de) 1998-05-28 1999-12-02 Probiodrug Ges Fuer Arzneim Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
GB9927603D0 (en) * 1999-11-22 2000-01-19 Nestle Sa Use of a milk protein hydrolysate in the treatment of diabetes
DE69930464D1 (de) * 1999-12-30 2006-05-11 Kerry Group Services Ltd Aufbaupräparat, das Kohlenhydrat- und Peptidmaterial enthält und sein Gebrauch als Energieergänzung nach oder während körperlicher Übung oder als metabolischer Nährstoff für die orale Verabreichung
JP2005538704A (ja) * 2002-07-01 2005-12-22 ユニリーバー・ナームローゼ・ベンノートシヤープ 満腹誘導組成物
US20060171992A1 (en) 2002-12-20 2006-08-03 Gerhardt Cinderella C Blood glucose regulating composition
EP1591116A4 (fr) * 2003-02-06 2008-05-28 Otsuka Pharma Co Ltd Inhibiteur de l'augmentation du taux de glycemie peri-operatoire
CN100435788C (zh) * 2003-02-06 2008-11-26 株式会社大塚制药工场 围术期血糖值上升抑制剂
JP2005289861A (ja) 2004-03-31 2005-10-20 Meiji Seika Kaisha Ltd グリコーゲンの貯蔵促進用の組成物
JP4229933B2 (ja) * 2004-08-31 2009-02-25 株式会社マルハニチロ食品 サケ由来アンジオテンシンｉ変換酵素阻害ペプチド化合物またはそれを含有するペプチド組成物とそれらの製造方法
JP4564330B2 (ja) 2004-10-19 2010-10-20 住友大阪セメント株式会社 高強度コンクリートの初期乾燥ひび割れ防止方法
WO2006068480A2 (fr) * 2004-12-23 2006-06-29 Campina Nederland Holding B.V. Hydrolysat de proteines enrichi en peptides inhibant dpp-iv et utilisation de ce dernier
US20090111747A1 (en) * 2005-02-14 2009-04-30 Harry Stephen Ewart Anti-Diabetic or Anti-Hypertensive Dietary Supplement
EP1941896A4 (fr) * 2005-09-20 2010-01-27 Kyowa Hakko Bio Co Ltd Composition contenant un dipeptide pour administration orale
CA2627566A1 (fr) * 2005-10-28 2007-05-10 Nestec S.A. Methodes d'emploi d'acides amines a chaine ramifiee
SI2032134T1 (sl) * 2006-05-09 2015-10-30 Genzyme Corporation Postopki zdravljenja bolezni zamaščenih jeter, ki obsegajo inhibicijo sintezo glukosfingolipida

Also Published As

Publication number Publication date
US20090124560A1 (en) 2009-05-14
CN101426513A (zh) 2009-05-06
CA2649842A1 (fr) 2007-11-01
JPWO2007123200A1 (ja) 2009-09-03
WO2007123200A1 (fr) 2007-11-01
US8343531B2 (en) 2013-01-01
JP2013091668A (ja) 2013-05-16
CN101426513B (zh) 2013-05-01
EP2039366A1 (fr) 2009-03-25
JP5728512B2 (ja) 2015-06-03
KR101652778B1 (ko) 2016-08-31
KR20090005202A (ko) 2009-01-12
EP2039366A4 (fr) 2010-01-06
JP5645360B2 (ja) 2014-12-24
CA2649842C (fr) 2015-02-17

Similar Documents

Publication Publication Date Title
HK1127877A1 (en) Composition containing peptide as the active ingredient
IL195488A (en) Compounds, pharmaceuticals containing them and their uses
EP2130552A4 (fr) Composition pharmaceutique comportant un anticorps anti-grp 78 en tant qu'ingredient actif
EP2078731A4 (fr) Composition pharmaceutique comprenant un anticorps anti-hb-egf comme ingrédient actif
ZA200709239B (en) Compositions for administering RNAIII-inhibiting peptides
HK1198914A1 (en) Novel dosage formulation
IL200746A0 (en) Cyclopamine analog compounds, compositions comprising the same and uses thereof
ZA200607014B (en) Insecticide composition
IL186336A0 (en) Pharmaceutical composition
IL187748A0 (en) Pharmaceutical compositions containing misoprostal
IL188352A0 (en) Pharmaceutical compositions
ZA200804103B (en) Pharmaceutical compositions
EP1937255A4 (fr) Composition pharmaceutique
EP1862184A4 (fr) Composition pharmaceutique
EP1904525A4 (fr) Compositions pharmaceutiques de glp-1
IL192824A (en) Peptide compounds, pharmaceuticals containing them and their use
GB0522045D0 (en) Pharmaceutical compositions
IL192091A0 (en) Pharmaceutical compositions
EP1845944A4 (fr) Compositions pharmaceutiques
EP1852119A4 (fr) Préparation pharmaceutique contenant un dérivé de phénoxazinium au titre de principe actif
ZA200803566B (en) Pharmaceutical compositions
GB0514259D0 (en) Pharmaceutical compositions
ZA200808768B (en) Pharmaceutical composition containing the NMB0606 protein
GB0511801D0 (en) Pharmaceutical composition
GB0518166D0 (en) Pharmaceutical composition